The Longevity Show

Show Notes

Why Normal Labs Miss Your Fitness Decline

Brooks Leitner of VO Health on estimating VO2 max from blood, and why a clean lab panel can still hide falling cardiorespiratory fitness.

Brooks Leitner, VO HealthJuly 8, 2026Episode resources
Hillary Lin, MD and Brooks Leitner on a clinical YouTube thumbnail reading GOOD LABS. LOW VO2?.

Watch/listen links and cut-accurate chapters will be added after the final cut is live.

Read the full guide

Standard lab panels can look normal while cardiorespiratory fitness quietly declines. VO2 max is one of the strongest predictors of long-term mortality, yet it rarely shows up on a routine blood draw. In this conversation, Brooks Leitner of VO Health explains why the gap exists and what it would take to close it.

We also get into the science behind blood-protein estimates of VO2 max. These signals are genuinely interesting, but they are early. A blood-based estimate is not a substitute for cardiopulmonary exercise testing (CPET), and we keep that distinction clear throughout.

Top takeaways

What matters clinically

01

VO2 max tracks mortality risk more tightly than most numbers on a standard panel, and a normal lab result does not rule out a declining trajectory.

02

Blood-protein estimates of VO2 max are an early research direction, not a validated clinical tool, and should be read as interesting signal rather than a diagnosis.

03

CPET remains the reference standard for measuring cardiorespiratory fitness. A blood estimate may point you toward testing, but it does not replace it.

04

Fitness is worth tracking on its own terms. It does not cancel other risk factors like ApoB, blood pressure, or glucose, and those still need their own attention.

Chapters

Episode map

TBD

What VO2 max actually measures

Why cardiorespiratory fitness is a distinct axis of health, not a byproduct of a good lipid panel.

TBD

The blind spot in normal labs

How a clean panel can coexist with a declining VO2 max, and why that matters for longevity.

TBD

Inside the blood-protein approach

What VO Health is trying to estimate from blood, and where the biology is promising versus unproven.

TBD

Estimate versus measurement

How a blood-based number compares to CPET, and the limits of any proxy for gas-exchange testing.

TBD

Reading the number responsibly

How to treat an early-stage estimate without overinterpreting it or skipping validated testing.

TBD

What to track and act on

Practical framing for fitness alongside ApoB, blood pressure, and glucose, without overclaiming.